{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:05:30Z","timestamp":1649045130207},"reference-count":21,"publisher":"Japanese Society of Internal Medicine","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J. Jpn. Soc. Intern. Med.","J. Jpn. Soc. Intern. Med"],"published-print":{"date-parts":[[2008]]},"DOI":"10.2169\/naika.97.1778","type":"journal-article","created":{"date-parts":[[2012,7,31]],"date-time":"2012-07-31T22:31:47Z","timestamp":1343773907000},"page":"1778-1783","source":"Crossref","is-referenced-by-count":2,"title":["3. Damages of Neuromuscular Junctions"],"prefix":"10.2169","volume":"97","author":[{"given":"Masakatsu","family":"Motomura","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Waterman SA: Autonomic dysfunction in Lambert-Eaton myasthenic syndrome. Clin Auton Res 11: 145-154, 2001.","DOI":"10.1007\/BF02329922"},{"key":"3","doi-asserted-by":"crossref","unstructured":"4) Clouston PD, et al: Paraneoplastic cerebellar degeneration. III. Cerebellar degeneration, cancer, and the Lambert-Eaton myasthenic syndrome. Neurology 42: 1944-1950, 1992.","DOI":"10.1212\/WNL.42.10.1944"},{"key":"4","doi-asserted-by":"crossref","unstructured":"5) Graus F, et al: P\/Q type calcium-channel antibodies in paraneoplastic cerebellar degeneration with lung cancer. Neurology 59: 764-766, 2002.","DOI":"10.1212\/WNL.59.5.764"},{"key":"5","doi-asserted-by":"publisher","DOI":"10.1002\/ana.10392"},{"key":"6","doi-asserted-by":"publisher","DOI":"10.1002\/mus.10087"},{"key":"7","doi-asserted-by":"crossref","unstructured":"8) Urbano FJ, et al: Calcium channels involved in neurotransmitter release at adult, neonatal and P\/Q-type deficient neuromuscular junctions. Mol Membr Biol 19: 293-300, 2002.","DOI":"10.1080\/0968768021000035087"},{"key":"8","doi-asserted-by":"crossref","unstructured":"9) Iwasa K, et al: LEMS IgG binds to extracellular determinants on N-type voltage-gated calcium channels, but does not reduce VGCC expression. Ann N Y Acad Sci 998: 196-199, 2003.","DOI":"10.1196\/annals.1254.020"},{"key":"9","doi-asserted-by":"crossref","unstructured":"10) Takamori M, et al: Antibodies to calcium channel and synaptotagmin in Lambert-Eaton myasthenic syndrome. Am J Med Sci 319: 204-208, 2000.","DOI":"10.1097\/00000441-200004000-00002"},{"key":"10","doi-asserted-by":"crossref","unstructured":"11) Takamori M, et al: Autoantibodies against M1 muscarinic acetylcholine receptor in myasthenic disorders. Eur J Neurol 14 (11): 2007.","DOI":"10.1111\/j.1468-1331.2007.01931.x"},{"key":"11","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000281663.81079.24"},{"key":"12","doi-asserted-by":"crossref","unstructured":"13) Nakao YK, et al: Seronegative Lambert-Eaton myasthenic syndrome: study of 110 Japanese patients. Neurology 59: 1773-1775, 2002.","DOI":"10.1212\/01.WNL.0000037485.56217.5F"},{"key":"13","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0437991100"},{"key":"14","doi-asserted-by":"crossref","unstructured":"16) AAEM Quality, Assurance Committee: American Association of Electrodiagnostic Medicine. Literature review of the usefulness of repetitive nerve stimulation and single fiber EMG in the electrodiagnostic evaluation of patients with suspected myasthenia gravis or Lambert-Eaton myasthenic syndrome. Muscle Nerve 24: 1239-1247, 2001.","DOI":"10.1002\/mus.1140"},{"key":"15","doi-asserted-by":"crossref","unstructured":"17) Baslo MB, et al:Decrement pattern in Lambert-Eaton myasthenic syndrome is different from myasthenia gravis. Neuromuscul Disord16 (7), 2006.","DOI":"10.1016\/j.nmd.2006.05.009"},{"key":"16","doi-asserted-by":"crossref","unstructured":"18) Hatanaka Y, Oh SJ: Ten-second exercise is superior to 30-second exercise for post-exercise facilitation in diagnosing Lambert-Eaton myasthenic syndrome. Muscle Nerve (null), (null), 2008.","DOI":"10.1002\/mus.20979"},{"key":"17","doi-asserted-by":"crossref","unstructured":"19) Martin-Moutot N, et al:Phoneutria nigriventer omega-Phonetoxin IIA: a new tool for anti-calcium channel autoantibody assays in Lambert-Eaton myasthenic syndrome. Neurobiol Dis 22 (1), 2006.","DOI":"10.1016\/j.nbd.2005.10.003"},{"key":"18","doi-asserted-by":"crossref","unstructured":"20) Chalk CH, et al: Response of the Lambert-Eaton myasthenic syndrome to treatment of associated small-cell lung carcinoma. Neurology 40: 1552-1556, 1990.","DOI":"10.1212\/WNL.40.10.1552"},{"key":"19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1749-6632.1998.tb11023.x"},{"key":"20","doi-asserted-by":"crossref","unstructured":"22) Maddison P, Newsom-Davis J: Treatment for Lambert-Eaton myasthenic syndrome. Cochrane Database Syst Rev18: CD003279 2005.","DOI":"10.1002\/14651858.CD003279.pub2"},{"key":"21","doi-asserted-by":"crossref","unstructured":"24) Flink MT, Atchison WD: Passive transfer of Lambert-Eaton syndrome to mice induces dihydropyridine sensitivity of neuromuscular transmission. J Physiol 543: 567-576, 2002.","DOI":"10.1113\/jphysiol.2002.021048"}],"container-title":["Nihon Naika Gakkai Zasshi"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/97\/8\/97_1778\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T16:42:46Z","timestamp":1621442566000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/naika\/97\/8\/97_1778\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.2169\/naika.97.1778","relation":{},"ISSN":["0021-5384","1883-2083"],"issn-type":[{"value":"0021-5384","type":"print"},{"value":"1883-2083","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008]]}}}